Literature DB >> 25499312

The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by D-galactosamine in rats.

Jianxing Luo1, Yang Zhang2, Xiaoyu Hu3, Sen Zhong2, Guo Chen2, Yanyan Wang2, Wu Lin2, Cheng Yi4, Hong Zhu4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Modified sini decoction (MSND) is a well-known traditional Chinese medical formula that has been used to treat cardiovascular and liver diseases for many years. We investigated the effects of MSND on acute liver failure and identified the possible mechanisms of these effects.
MATERIAL AND METHODS: Acute liver failure was induced by intraperitoneal injection of d-galactosamine (d-GalN) into specific pathogen-free male Wistar rats. Next, the rats were treated with Stronger Neo-Minophagen C and MSND via gavage. Biochemical parameters, histological changes in the liver, the survival of rats and the mRNA levels of toll-like receptor 4 (TLR4), nuclear factor kappa B (NF-κB), high mobility group box 1 (HMGB1) caspase-3 and proliferating cell nuclear antigen (PCNA) were analyzed.
RESULTS: MSND prolonged the survival times of the acute liver failure rats. The biochemical parameters were improved, and necrosis in the liver tissues was reduced by both Stronger Neo-Minophagen C (SNMC) and MSND, but MSND induced greater effects. The mRNA expressions of HMGB1, TLR4, NF-κB, and Caspase-3 were remarkably decreased, and the expression of PCNA was remarkably increased by SNMC and MSND, and the effects of MSND were greater.
CONCLUSIONS: MSND protected the liver and increased the survival rate of acute liver failure rats. These effects were likely mediated by the inhibitions of the inflammatory reaction and apoptosis and the promotion of liver tissue regeneration.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; HE staining; Inflammation; Liver function; RT-PCR

Mesh:

Substances:

Year:  2014        PMID: 25499312     DOI: 10.1016/j.jep.2014.12.003

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  10 in total

1.  Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model.

Authors:  Lunjie Lu; Jun Zhou; Jingying Zhang; Jun Che; Yang Jiao; Yusong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-04       Impact factor: 2.629

Review 2.  Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes.

Authors:  Priyanka Saha; Anupam Das Talukdar; Rajat Nath; Satyajit D Sarker; Lutfun Nahar; Jagajjit Sahu; Manabendra Dutta Choudhury
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

3.  The Effect of Modified Sini Decoction on Survival Rates of Patients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure.

Authors:  Jian-Xing Luo; Yang Zhang; Xiao-Yu Hu; Chang Yu
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-24       Impact factor: 2.629

4.  Sini Decoction Intervention on Atherosclerosis via PPARγ-LXRα-ABCA1 Pathway in Rabbits.

Authors:  Shicong Ju; Xiaorong Chang; Jun Wang; Xufeng Zou; Zhao Zhao; Zhen Huang; Yuanhong Wang; Baosheng Yu
Journal:  Open Life Sci       Date:  2018-11-09       Impact factor: 0.938

5.  Detoxification II Prescription Suppresses the Th-17/IL-17 Inflammatory Axis to Improve the Liver Function of ACLF-Rats via Inactivating the P38MAPK Pathway.

Authors:  Qinglan Shi; Wenjie Bai; Dewen Mao; Yueqiao Chen; Kejing Wang; Hua Qiu; Jinyu Wu
Journal:  J Healthc Eng       Date:  2021-12-03       Impact factor: 2.682

6.  The Key Molecular Mechanisms of Sini Decoction Plus Ginseng Soup to Rescue Acute Liver Failure: Regulating PPARα to Reduce Hepatocyte Necroptosis?

Authors:  Ying He; Yang Zhang; Junli Zhang; Xiaoyu Hu
Journal:  J Inflamm Res       Date:  2022-08-22

7.  The Effects of Taoren-Honghua Herb Pair on Pathological Microvessel and Angiogenesis-Associated Signaling Pathway in Mice Model of CCl4-Induced Chronic Liver Disease.

Authors:  Shengyan Xi; Lifeng Yue; Mengmeng Shi; Ying Peng; Yangxinzi Xu; Xinrong Wang; Qian Li; Zhijun Kang; Hanjing Li; Yanhui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-11       Impact factor: 2.629

8.  Drug target identification using network analysis: Taking active components in Sini decoction as an example.

Authors:  Si Chen; Hailong Jiang; Yan Cao; Yun Wang; Ziheng Hu; Zhenyu Zhu; Yifeng Chai
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

9.  Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula.

Authors:  Hai Zhang; Shifan Ma; Zhiwei Feng; Dongyao Wang; Chengjian Li; Yan Cao; Xiaofei Chen; Aijun Liu; Zhenyu Zhu; Junping Zhang; Guoqing Zhang; Yifeng Chai; Lirong Wang; Xiang-Qun Xie
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

10.  SHYCD induces APE1/Ref-1 subcellular localization to regulate the p53-apoptosis signaling pathway in the prevention and treatment of acute on chronic liver failure.

Authors:  Jianxin Diao; Haiye Li; Wei Huang; Wenxiao Ma; Huan Dai; Yawei Liu; Ming Wang; He Yu Hua; Jinying Ou; Xiaomin Sun; Xuegang Sun; Yungao Yang
Journal:  Oncotarget       Date:  2017-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.